Sotera Health (NASDAQ:SHC) Raised to “Strong-Buy” at The Goldman Sachs Group

Sotera Health (NASDAQ:SHC) was upgraded by equities researchers at The Goldman Sachs Group to a “strong-buy” rating in a note issued to investors on Friday,Zacks.com reports.

A number of other equities research analysts also recently issued reports on SHC. Citigroup upped their price target on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Barclays reduced their target price on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Piper Sandler reissued an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and a consensus price target of $20.29.

Sotera Health Stock Performance

SHC opened at $15.62 on Friday. The firm has a market cap of $4.45 billion, a P/E ratio of 38.10 and a beta of 1.79. Sotera Health has a 1-year low of $10.80 and a 1-year high of $19.85. The company has a 50 day simple moving average of $15.37 and a two-hundred day simple moving average of $16.36. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities analysts forecast that Sotera Health will post 0.86 earnings per share for the current fiscal year.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 15.36% of the stock is currently owned by insiders.

Institutional Trading of Sotera Health

A number of institutional investors have recently modified their holdings of SHC. Sculptor Capital LP boosted its holdings in shares of Sotera Health by 57.4% in the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after buying an additional 7,658,200 shares in the last quarter. Sachem Head Capital Management LP boosted its holdings in shares of Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after buying an additional 3,735,000 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after buying an additional 2,756,583 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after buying an additional 2,644,831 shares in the last quarter. Finally, Norges Bank acquired a new stake in Sotera Health in the 4th quarter worth approximately $45,278,000. 91.03% of the stock is currently owned by institutional investors.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.